Buyer's Guide

Print version | PDF version | Recommend company

Portrait
Simcyp is a research-based company providing a modelling and simulation platform for predicting the fate of drugs in virtual populations, including paediatric populations. From this, individual patients likely to be at extreme risk from adverse reaction can be identified, and unnecessary exposure to human volunteers and animals can be minimised. The limitations of candidate compounds, including potential drug-drug interactions, can be assessed and managed prior to human studies, allowing better focus of drug development resources.

Simcyp licenses the platform - the Population-based ADME Simulator - offers consultancy services, and runs education programmes around the world.

Industrial Sectors

Pharmacy